Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.

ABSTRACT

ConditionSARS-CoV Infection;Covid19

InterventionOther biobank

Primary outcome:Percentage of patients hospitalized (if the patient was outpatient) or whose hospitalization was extended for complications from COVID-19 within 1 month of symtoms' onset.

Criteria
Inclusion Criteria

- Adults with the criteria for COVID-19 treatment within the French compassionate
program (ATU/AAP)

- Adults covered by the French social health coverage

- Adults who signed the informed consent form

Exclusion Criteria

- Exclusion criteria described in the French compassionate program (ATU/AAP)

- Patient participating in another biomedical research with an exclusion period ongoing
at inclusion

- Vulnerable patient (adults legally protected under judicial protection, guardianship,
or supervision, persons deprived of their liberty)

- Pregnant or breastfeeding woman